Recent News

567 News Items found
Pictured: Michael Foley
Announcement
A renowned chemist with 25 years of industry and academic experience, Michael Foley will lead a pioneering collaboration designed to speed the development of new drugs for people with cancer and other diseases.
Pictured: Joan Massagué
Announcement
Internationally recognized cancer biologist Joan Massagué has been named Director of the Sloan Kettering Institute. He was previously Chair of the Cancer Biology and Genetics Program at Memorial Sloan Kettering.
Pictured: Stephen Long & Alexandria Miller
Profile
At Work: Structural Biologist Stephen Long
Stephen Long works to understand how proteins work by determining what they look like in three dimensions.
Pictured: Craig Thompson
Event
Memorial Sloan Kettering’s annual seminar exposes high school students and their teachers to cutting-edge scientific research.
Pictured: Laurie Glimcher, Craig Thompson, Marc Tessier-Lavigne & Tadataka Yamada
Announcement
Memorial Sloan Kettering is joining with two other academic institutions in a pioneering collaboration to speed early-stage drug discoveries into therapies for patients.
Pictured: Emily Foley
Profile
At Work: Cell Biologist Emily Foley
Memorial Sloan Kettering cell biologist Emily Foley discusses her research, which is focused on improving the understanding of cell division.
Mouse glioblastoma tumor with phagocytic macrophages
In the Lab
Memorial Sloan Kettering researchers say a drug that acts on noncancerous, tumor-infiltrating cells might provide a new treatment option for the most common and aggressive type of brain cancer.
Pictured: James E. Rothman, Thomas C. Südhof & Randy W. Schekman
Honors
James Rothman, who receives this year’s Nobel Prize in Physiology or Medicine together with Randy Schekman and Thomas Südhof, conducted more than a decade of his seminal research at Memorial Sloan Kettering.
Pictured: Pseudomonas aeruginosa
Snapshot
Memorial Sloan Kettering researchers have discovered how a common bacterium can evolve to become more mobile and easier to get rid of.
Pictured: Daniel Thorek & Jan Grimm
In the Lab
A new imaging approach being investigated by Memorial Sloan Kettering researchers could provide better information about a tumor’s molecular activity, allowing for a more accurate diagnosis.